Page last updated: 2024-11-02

pd 98059 and Leukemia, Megakaryocytic

pd 98059 has been researched along with Leukemia, Megakaryocytic in 2 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Looi, CY1
Imanishi, M1
Takaki, S1
Sato, M1
Chiba, N1
Sasahara, Y1
Futaki, S1
Tsuchiya, S1
Kumaki, S1
Kalina, U1
Koschmieder, S1
Hofmann, WK1
Wagner, S1
Kauschat, D1
Hoelzer, D1
Ottmann, OG1

Other Studies

2 other studies available for pd 98059 and Leukemia, Megakaryocytic

ArticleYear
Octa-arginine mediated delivery of wild-type Lnk protein inhibits TPO-induced M-MOK megakaryoblastic leukemic cell growth by promoting apoptosis.
    PloS one, 2011, Volume: 6, Issue:8

    Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Prolife

2011
Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.
    Experimental hematology, 2001, Volume: 29, Issue:5

    Topics: Cell Differentiation; Cell Division; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Ery

2001